Preventive effect of ipragliflozin on nocturnal hypoglycemia in patients with type 2 diabetes treated with basal‐bolus insulin therapy: An open‐label, single‐center, parallel, randomized control study

The efficacy of the administration of sodium‐glucose co‐transporter 2 inhibitor or the co‐administration of sodium‐glucose co‐transporter 2 inhibitor and dipeptidyl peptidase‐4 inhibitor to insulin therapy is not well known. A total of 58 patients with type 2 diabetes, admitted for glycemic control,...

Descripción completa

Detalles Bibliográficos
Autores principales: Okajima, Fumitaka, Nagamine, Tomoko, Nakamura, Yuko, Hattori, Naomi, Sugihara, Hitoshi, Emoto, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415488/
https://www.ncbi.nlm.nih.gov/pubmed/27762088
http://dx.doi.org/10.1111/jdi.12588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415488/
https://www.ncbi.nlm.nih.gov/pubmed/27762088
http://dx.doi.org/10.1111/jdi.12588

Ejemplares similares